Climb Bio, Inc. CLYM
NASDAQ · United States · Health Technology
$10.94-0.13 (-1.17%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-06 | -0.18 | -0.21 | +14.0% | $0 | — | +12.3%$12.47→$14.00 |
| Q1 2026 | 2026-05-07 | -0.20 | -0.26 | +23.1% | — | — | -7.0%$12.22→$11.37 |
| Q4 2025 | 2026-03-05 | -0.26 | -0.21 | -23.8% | — | — | -1.4%$7.28→$7.18 |
| Q3 2025 | 2025-11-06 | -0.19 | -0.16 | -18.8% | — | — | -4.7%$1.92→$1.83 |
| Q2 2025 | 2025-08-12 | -0.13 | -0.18 | +27.8% | — | — | — |
| Q1 2025 | 2025-05-14 | -0.31 | -0.15 | -106.7% | — | — | — |
| Q4 2024 | 2025-03-25 | 0.04 | -0.15 | +126.7% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.